ArticleVirchows Archiv : an international journal of pathology2022

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.

Eun Young Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.